Demand for the new weight-loss tablet is high, supply is building, and that combination reliably produces two things: legitimate services working through assessments, and illegitimate sellers promising to skip them. This article maps the safe routes to the Wegovy pill in the UK, what each involves, and the warning signs that a route is not safe at all. The single organising fact: this is a prescription-only medicine, and every legitimate path runs through a clinical assessment, whoever provides it.
Route one: the NHS
The NHS route starts with your GP practice: a conversation about your weight, health conditions and what is commissioned locally. NHS access to weight-loss medicines prioritises the greatest clinical need, typically tighter criteria than the product licence, and in many areas runs through specialist weight-management services by referral. It is the right route if you meet the higher-need criteria and can work with the timescales; it costs nothing at the point of use and wraps structured support around treatment. Our separate article on the Wegovy pill and the NHS covers the machinery in detail. If NHS criteria or waits do not fit your situation, that is what the regulated private routes exist for.
Route two: registered pharmacies, online or on the high street
Private access runs through pharmacies and clinics registered with the General Pharmaceutical Council, many operating online with prescriber-led services. The legitimate process has a recognisable shape regardless of brand. You complete a structured medical questionnaire covering your weight history, conditions and medicines. The service verifies your identity and your weight, commonly through photographs or video, because paper self-declaration is too easy to game for a medicine with real risks. A prescriber reviews the whole picture and makes an individual decision, sometimes with follow-up questions. If prescribed, the medicine is dispensed by the registered pharmacy with the dose schedule, side-effect guidance and a plan for reviews. The friction in that process is the safety; a service without it is not a shortcut but a red flag.
The route to refuse: no-assessment sellers
The gap between demand and supply is filled by sellers on social media, marketplaces and unregistered websites offering weight-loss medicines with no prescription, no questions and improbable availability. The MHRA and pharmacy bodies have repeatedly warned about this trade, and the documented findings are grim: counterfeit products containing the wrong dose, different drugs entirely, including insulin in fake weight-loss pens, or nothing identifiable. With a tablet the risk compounds, because a counterfeit pill reveals nothing about itself before it is swallowed. The tell is always the same: genuine semaglutide is never legally sold in the UK without a prescription, so anyone offering it that way is by definition operating outside the system that checks what is actually in the product. No saving and no waiting-list frustration makes that trade rational.
What happens after the prescription
Getting the medicine is the start of treatment, not the end of the process, and a legitimate provider stays involved. Expect the dose to build in steps over months, with the option to hold a step longer if side effects need it. Expect reviews that check progress, tolerability and anything new in your health, and honest conversations if results disappoint, covering routine, habits, dose and alternatives. Expect the practical guidance too: the tablet's strict empty-stomach routine is the part most people underestimate, and our guides on how to take the Wegovy pill and what to eat alongside it cover the daily reality. A service that dispenses repeats without ever reviewing you is delivering the medicine but not the treatment; it is worth expecting better, and saying so.
Getting started
The practical sequence is short. Check your eligibility honestly against the criteria, BMI 30 and above, or 27 and above with a weight-related condition, using a real measurement rather than a guess. Decide your route: GP conversation first if you may sit in the NHS priority groups, or a registered private service if not. Verify the provider against the checklist above. Complete the assessment with full honesty, since every omission removes a safety check protecting you specifically. And go in with realistic expectations: appetite changes early, weight changes over months, side effects are usually a manageable early phase, and the medicine works alongside eating and activity changes rather than instead of them. Our complete guide to the Wegovy pill is the sensible pre-reading for the whole journey.
If supply is short when you apply
New weight-loss medicines have repeatedly launched into more demand than supply, and it is worth deciding in advance how you will respond if the tablet is temporarily unavailable when you are approved. The good options: join the provider's list and wait, since supply has always caught up; or discuss starting the weekly semaglutide injection instead, which is the same medicine with a longer track record, and switching to the tablet later under clinical guidance if you still prefer it. The bad option is the one shortages are designed to sell you: the seller who mysteriously has unlimited stock of a constrained medicine, no prescription required. Constrained supply flows through regulated channels first; abundant supply outside them is its own warning. A few weeks of patience inside the system beats any outcome available outside it. If you do start on the injection while waiting for tablet stock, treat it as a genuine trial rather than a placeholder; a meaningful number of people discover the weekly routine suits them and never make the switch they originally planned.
